Gastric cancer: Basic aspects
Abstract
Despite major breakthroughs in the field of personalized medicine, gastric cancer (GC) remains a clinically challenging disease, characterized by scarce effective treatment options and the lack of reliable molecular tools for the prediction of patient outcome and response to therapy. The pronounced molecular heterogeneity that dictates the phenotypical aggressiveness of gastric neoplasms severely limits the antitumor efficacy of targeted agents brought to clinical trials, and constitutes a favorable setting for the emergence of refractory tumors exhibiting multidrug resistance. We will review the most recent advances in our understanding of GC biology, which are underlying the development and clinical testing of novel targeted therapeutic agents. We will also emphasize how their efficacy and acquired resistance relate to the aberrant molecular signatures that drive gastric malignancy.
Citing Literature
Number of times cited according to CrossRef: 11
- Xianglian Tang, Yong Li, Ming Li, Yuxiang Zhou, Jiabing Wen, Zhao Huang, Yaling Xiao, The role of long noncoding RNAs in regulating invasion and metastasis of malignant tumors, Anti-Cancer Drugs, 10.1097/CAD.0000000000000899, 31, 4, (319-325), (2020).
- Xiaokun Lin, Lihua Wang, Liqian Zhao, Zheng Zhu, TongZuan Chen, Shinuo Chen, Yecheng Tao, Tianni Zeng, Yaoyao Zhong, Hanxiao Sun, Zhixiang Wang, Weisheng Zheng, Yuhao Zhang, Wencan Wu, Kaihui Nan, Tongke Chen, Curcumin micelles suppress gastric tumor cell growth by upregulating ROS generation, disrupting redox equilibrium and affecting mitochondrial bioenergetics, Food & Function, 10.1039/D0FO00260G, (2020).
- Laura Necula, Lilia Matei, Denisa Dragu, Ioana Pitica, Ana Iulia Neagu, Coralia Bleotu, Simona Dima, Irinel Popescu, Carmen C Diaconu, Mihaela Chivu-Economescu, High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients, World Journal of Gastroenterology, 10.3748/wjg.v26.i22.3024, 26, 22, (3024-3033), (2020).
- Jiamin He, Qiwei Ge, Zhenghua Lin, Weiyi Shen, Renbin Lin, Jiaguo Wu, Boya Wang, Yunkun Lu, Luyi Chen, Xiaosun Liu, Wenfang Zheng, Ying Zhang, Lan Wang, Kan Wang, Liangjing Wang, Wei Zhuo, Shujie Chen, MiR‐129‐5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression, The FASEB Journal, 10.1096/fj.201903217R, 34, 6, (8544-8557), (2020).
- Jiying Deng, Qin Zhang, Lianwei Lu, Chunxia Fan,
Long Noncoding RNA DLGAP1-AS1 Promotes the Aggressive Behavior of Gastric Cancer by Acting as a ceRNA for microRNA-628-5p and Raising Astrocyte Elevated Gene 1 Expression
, Cancer Management and Research, 10.2147/CMAR.S246166, Volume 12, (2947-2960), (2020). - Yan Qian, Xu Wu, Haixiao Wang, Guowei Hou, Xiao Han, Wei Song, PAK1 silencing is synthetic lethal with CDK4/6 inhibition in gastric cancer cells via regulating PDK1 expression, Human Cell, 10.1007/s13577-019-00317-6, (2020).
- Zepang Sun, Hao Chen, Zhen Han, Weicai Huang, Yanfeng Hu, Mingli Zhao, Tian Lin, Jiang Yu, Hao Liu, Yuming Jiang, Guoxin Li, Genomics Score Based on Genome-Wide Network Analysis for Prediction of Survival in Gastric Cancer: A Novel Prognostic Signature, Frontiers in Genetics, 10.3389/fgene.2020.00835, 11, (2020).
- Haoming Lu, Ying Feng, Yilin Hu, Yibing Guo, Yifei Liu, Qinsheng Mao, Wanjiang Xue, Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells, Journal of Cellular and Molecular Medicine, 10.1111/jcmm.14618, 24, 1, (98-113), (2019).
- Hongbing Zhai, Yanju Li, BCYRN1 is correlated with progression and prognosis in gastric cancer, Bioscience Reports, 10.1042/BSR20190505, 39, 11, (2019).
- Yi He, Minjie Mao, Wenjuan Shi, Zhonglian He, Lin Zhang, Xueping Wang, Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection, Journal of Translational Medicine, 10.1186/s12967-019-1841-3, 17, 1, (2019).
- Alexios-Fotios A. Mentis, Marina Boziki, Nikolaos Grigoriadis, Athanasios G. Papavassiliou, Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword, Cellular and Molecular Life Sciences, 10.1007/s00018-019-03044-1, (2019).
